Stocks
Zimmer Biomet Holdings Financial Statements (ZBH) |
||||||||||
| Zimmer Biomet Holdingssmart-lab.ru | % | 2021 | 2021 | 2022 | 2022 | 2023 | LTM ? | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Report date | 07.02.2022 | 25.02.2022 | 31.12.2022 | 24.02.2023 | 23.02.2024 | 30.10.2024 | ||||
| Currency | USD | USD | USD | USD | USD | USD | ||||
| Financial report URL | ||||||||||
| Revenue, bln rub | ? | 7 836 | 6 827 | 6 940 | 6 940 | 7 394 | 7 596 | |||
| Operating Income, bln rub | -1 561 | 860.3 | 696.3 | 1 064 | 1 278 | 1 376 | ||||
| EBITDA, bln rub | ? | 1 277 | 2 160 | 1 495 | 2 213 | 2 449 | 2 510 | |||
| Net profit, bln rub | ? | 402.0 | 401.6 | 291.2 | 231.4 | 1 024 | 1 084 | |||
| OCF, bln rub | ? | 1 499 | 1 499 | 1 356 | 1 285 | 1 582 | 1 582 | |||
| CAPEX, bln rub | ? | 172.0 | 152.0 | 187.9 | 187.9 | 689.2 | 423.8 | |||
| FCF, bln rub | ? | 1 327 | 1 347 | 1 168 | 1 097 | 892.4 | 1 158 | |||
| Dividend payout, bln rub | 200.1 | 200.1 | 201.2 | 201.2 | 200.9 | 198.2 | ||||
| Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||||
| Dividend payout ratio, % | 49.8% | 49.8% | 69.1% | 86.9% | 19.6% | 18.3% | ||||
| OPEX, bln rub | 7 056 | 3 862 | 4 224 | 3 728 | 3 276 | 4 198 | ||||
| Cost of production, bln rub | 2 341 | 1 960 | 2 020 | 2 020 | 2 084 | 2 561 | ||||
| R&D, bln rub | 497.0 | 435.8 | 406.0 | 406.0 | 458.7 | 442.2 | ||||
| Interest expenses, bln rub | 208.0 | 208.4 | 164.8 | 164.8 | 201.2 | 206.4 | ||||
| Assets, bln rub | 23 456 | 23 456 | 21 066 | 21 066 | 21 497 | 21 720 | ||||
| Net Assets, bln rub | ? | 0.000 | 12 661 | 12 027 | 12 021 | 12 481 | 12 375 | |||
| Debt, bln rub | 5 463 | 7 079 | 5 697 | 5 697 | 5 995 | 6 573 | ||||
| Cash, bln rub | 478.0 | 378.1 | 375.7 | 375.7 | 415.8 | 569.0 | ||||
| Net debt, bln rub | 4 985 | 6 701 | 5 321 | 5 321 | 5 579 | 6 004 | ||||
| Ordinary share price, rub | 159.9 | 123.2 | 127.5 | 127.5 | 121.7 | 108.2 | ||||
| Number of ordinary shares, mln | 208.9 | 208.6 | 209.6 | 209.6 | 208.7 | 202.3 | ||||
| Market cap, bln rub | 33 401 | 25 708 | 26 724 | 26 724 | 25 399 | 21 893 | ||||
| EV, bln rub | ? | 38 386 | 32 409 | 32 045 | 32 045 | 30 978 | 27 896 | |||
| Book value, bln rub | -15 491 | -1 792 | -1 617 | -1 623 | -1 194 | -1 203 | ||||
| EPS, rub | ? | 1.92 | 1.93 | 1.39 | 1.10 | 4.91 | 5.36 | |||
| FCF/share, rub | 6.35 | 6.46 | 5.57 | 5.23 | 4.28 | 5.72 | ||||
| BV/share, rub | -74.2 | -8.59 | -7.71 | -7.74 | -5.72 | -5.95 | ||||
| EBITDA margin, % | ? | 16.3% | 31.6% | 21.5% | 31.9% | 33.1% | 33.0% | |||
| Net margin, % | ? | 5.13% | 5.88% | 4.20% | 3.33% | 13.8% | 14.3% | |||
| FCF yield, % | ? | 3.97% | 5.24% | 4.37% | 4.10% | 3.51% | 5.29% | |||
| ROE, % | ? | 3.17% | 2.42% | 1.92% | 8.20% | 8.76% | ||||
| ROA, % | ? | 1.71% | 1.71% | 1.38% | 1.10% | 4.76% | 4.99% | |||
| P/E | ? | 83.1 | 64.0 | 91.8 | 115.5 | 24.8 | 20.2 | |||
| P/FCF | 25.2 | 19.1 | 22.9 | 24.4 | 28.5 | 18.9 | ||||
| P/S | ? | 4.26 | 3.77 | 3.85 | 3.85 | 3.43 | 2.88 | |||
| P/BV | ? | -2.16 | -14.3 | -16.5 | -16.5 | -21.3 | -18.2 | |||
| EV/EBITDA | ? | 30.1 | 15.0 | 21.4 | 14.5 | 12.6 | 11.1 | |||
| Debt/EBITDA | 3.90 | 3.10 | 3.56 | 2.40 | 2.28 | 2.39 | ||||
| R&D/CAPEX, % | 289.0% | 286.7% | 216.1% | 216.1% | 66.6% | 104.3% | ||||
| CAPEX/Revenue, % | 2.19% | 2.23% | 2.71% | 2.71% | 9.32% | 5.58% | ||||
| Zimmer Biomet Holdings shareholders | ||||||||||
